Cited by 1,151Genomics and Chromatin DynamicsChromatin Remodeling and CancerAcute Myeloid Leukemia Research

Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution

Open access
Corces, M Ryan, Buenrostro, Jason D, Wu, Beijing, Greenside, Peyton G, Chan, Steven M, Koenig, Julie L, Snyder, Michael P, Pritchard, Jonathan K +4 more·2016·Nature Genetics

Abstract

We define the chromatin accessibility and transcriptional landscapes in 13 human primary blood cell types that span the hematopoietic hierarchy. Exploiting the finding that the enhancer landscape better reflects cell identity than mRNA levels, we enable 'enhancer cytometry' for enumeration of pure cell types from complex populations. We identify regulators governing hematopoietic differentiation and further show the lineage ontogeny of genetic elements linked to diverse human diseases. In acute myeloid leukemia (AML), chromatin accessibility uncovers unique regulatory evolution in cancer cells with a progressively increasing mutation burden. Single AML cells exhibit distinctive mixed regulome profiles corresponding to disparate developmental stages. A method to account for this regulatory heterogeneity identified cancer-specific deviations and implicated HOX factors as key regulators of preleukemic hematopoietic stem cell characteristics. Thus, regulome dynamics can provide diverse insights into hematopoietic development and disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ng.3646

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Wider-ranging epigenetic alterations, especially perturbing key enhancer landscapes with high similarity to human disease, support a role in the myeloid disease.

    “our molecular analyses into gene regulatory circuits support a role for wider-ranging epigenetic alterations, especially perturbing key enhancer landscapes with high similarity to human disease (29).”

    From PU.1-Dependent Enhancer Inhibition Separates <i>Tet2</i> -Deficient Hematopoiesis from Malignant Transformation (2022) · cites this paper as [29]

    The Results section ('Synthetic normal analogs uncover AML-specific biology'; page unavailable) identifies altered regulatory modules in human acute myeloid leukemia, and the Discussion describes cancer-specific changes in chromatin accessibility. This supports the relevance of enhancer-associated epigenetic alterations to myeloid disease, but the source does not establish that the citing authors’ alterations have high similarity to those in human disease. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Genome-wide datasets of TF binding and chromatin accessibility are not informative regarding the functional role of each TF in a given sequence context.

    “Genome-wide datasets of TF binding and chromatin accessibility13,22,23 are not informative regarding the functional role of each TF in a given sequence context.”

    From Design principles of cell-state-specific enhancers in hematopoiesis (2025) · cites this paper as [23]

    The Results section ('Regulatory networks of normal hematopoiesis') says a motif sequence alone cannot identify the precise TF causing accessibility, especially when TFs share similar motifs. That supports a limitation of accessibility data, but not the broader claim that genome-wide TF-binding and accessibility datasets are uninformative about each TF’s functional role in a given sequence context. The paper also uses accessibility data, integrated with RNA-seq, to identify putative regulators. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • ARCH HSCs showed no discernible alterations of PU.1 mRNA levels compared with age-matched healthy individual-derived control cells.

    “ARCH HSCs, closely resembling the regulatory landscape that defines the transcriptional make-up, of non-ARCH, healthy multipotent progenitor (MPP) cells (29), showed no discernible alterations of PU.1 mRNA levels compared with age-matched healthy individual-derived control cells (Fig. 1A).”
  • In LSCs, PU.1 mRNA expression was found reduced to sub-haploinsufficient levels by 21% ± 4% (P < 0.01) compared with their healthy counterparts.

    “However, in LSCs, mostly sharing transcriptional programs with healthy granulocytic–monocytic progenitors (GMPs; ref. 29), PU.1 mRNA expression was found reduced to sub-haploinsufficient levels [by 21% ± 4% (P < 0.01) compared with their healthy counterparts; Fig. 1B].”
  • The strong effects of p300 inhibition on promoter activation support previous reports on the role of p300 catalytic activity in assembling the pre-initiation complex and recruiting RNA polymerase.

    “also supports previous reports on the role of the catalytic activity of p300 in assembling the pre-initiation complex (PIC) and recruiting RNA polymerase51.”

    From Single-molecule states link transcription factor binding to gene expression (2024) · cites this paper as [51]

    The Results section on regulatory networks of normal hematopoiesis discusses transcription-factor motifs and chromatin accessibility, not p300 catalytic activity. Searches for p300, pre-initiation complex assembly, and RNA polymerase recruitment found no passage addressing the attributed mechanism in our copy. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [1]Quesenberry PJ Colvin GA Hematopoietic Stem Cells, Progenitor Cells, and Cytokines Williams Hematology McGraw-Hill 2005

Cited by

Sorted by citations

Authors
Corces, M. R., Buenrostro, J. D., Wu, B., Greenside, P. G., Chan, S. M., Koenig, J. L., Snyder, M. P., Pritchard, J. K., Kundaje, A., Greenleaf, W. J., Majeti, R., & Chang, H. Y.
Affiliations
  • Stanford Medicine (US)
  • Broad Institute (US)
  • Stanford University (US)
  • University Health Network (CA)
  • Howard Hughes Medical Institute (US)
Corresponding author
  • Majeti, Ravindra
  • Chang, Howard Y
Venue
Nature Genetics
Published
2016-08-15
Volume
48
Issue
10
Pages
1193-1203
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W2514448720
Cited by
1,151
References
64
Citations by year
2026: 63 · 2025: 92 · 2024: 123 · 2023: 120 · 2022: 157 · 2021: 156 · 2020: 146 · 2019: 132 · 2018: 90 · 2017: 66 · 2016: 6
FWCI
50.92
Type
journal article
Language
en
Open access
Locations
  • Nature Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Howard Hughes Medical Institute
  • National Human Genome Research Institute (P50HG007735, K22HG000044, T32HG000044)
  • National Cancer Institute (R25CA180993, F31CA180659, R01CA188055, P30CA124435)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (UH2AR067676)
  • U.S. National Library of Medicine (T15LM007033)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Keywords
chromatin accessibility, hematopoiesis, acute myeloid leukemia, enhancer landscape, hematopoietic differentiation, regulatory evolution, mutational burden, transcriptional landscape, single-cell chromatin accessibility
MeSH terms
Chromatin, Clone Cells, Enhancer Elements, Genetic, Hematopoiesis, Humans, Regulatory Sequences, Nucleic Acid, Tumor Cells, Cultured, Leukemia, Myeloid, Acute, Gene Expression Regulation, Neoplastic, Sequence Analysis, DNA, Cell Lineage, Gene Expression Profiling, Myelopoiesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review